Men's Health News

RSS

ESHRE's first workshop on male infertility

ESHRE invites you to attend its first workshop on male infertility in Thessaloniki, Greece "Reproductive andrology: linking laboratory to clinical practice". The workshop provides a forum for clinicians and scientists to share research results and discuss new developments.

16 Sep 2009

Research study investigates survival rates of prostate cancer patients across time periods

New research to be published in tomorrow's issue of the Journal of the American Medical Association (JAMA) (Vol. 302, No. 11), by a team at The Cancer Institute of New Jersey (CINJ), shows that men diagnosed with prostate cancer beginning in the early 1990's had significantly improved survival outcomes compared with patients whose cancers were diagnosed in prior decades.

16 Sep 2009

Defective gene is linked to male infertility

Virginia Commonwealth University School of Medicine researchers have discovered a gene involved with the production of sperm that may contribute to male infertility and lead to new approaches to male contraception.

16 Sep 2009

Men and healthcare professionals urged to take proactive approach to prostate cancer

As prostate cancer is the third leading cause of cancer death in European men with more than 300,000 men being diagnosed every year, society needs to commit to changing the way the disease is viewed. Therefore a mini-symposium and lunch meeting are organized on 18 September 2009 in Antwerp on the occasion of the European launch of the Proactive Prostates Initiative, organized as part of Urology Week.

14 Sep 2009

GTx to continue its toremifene Phase III high grade PIN clinical trial for prevention of prostate cancer

GTx, Inc. (Nasdaq: GTXI), today announced that following a planned safety review, an independent Data Safety Monitoring Board (DSMB) has recommended that the company continue as planned the pivotal Phase III clinical trial evaluating toremifene 20 mg for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia (PIN), a precancerous lesion of the prostate.

14 Sep 2009

Body mass in younger and older adulthood linked to prostate cancer risks

A team of scientists led by researcher Brenda Hernandez, Ph.D., M.P.H.-an assistant professor at the University of Hawai'i at Mānoa's Cancer Research Center of Hawai'i-has reported that body mass in younger and older adulthood, and weight gain between these life periods, may influence a man's risk for prostate cancer. This risk varies among different ethnic groups, according to findings reported in a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

14 Sep 2009

Lack of awareness in aged men reagarding prostate cancer treatment options

Prostate cancer remains one of the most commonly diagnosed cancers in the United States. In fact, one in six men will develop prostate cancer. It is also the second-leading cause of cancer death in the United States. But a recent survey suggests that many men at risk for the cancer still aren't aware of all available treatment options.

10 Sep 2009

Prostate cancer treatment options discussed in a study

A new study in the Journal of the American Medical Association (JAMA) appears to support the theory outlined in earlier studies that men with more advanced forms of prostate cancer don't benefit from a combination of hormone and radiation therapy.

9 Sep 2009

Active cannabis chemicals halt prostate cancer cell growth

ACTIVE chemicals in cannabis have been shown to halt prostate cancer cell growth according to research published in the British Journal of Cancer today.

8 Sep 2009

FDA extends review period for Endo Pharmaceuticals' testosterone undecanoate

Endo Pharmaceuticals announced today that it has been informed by the U.S. Food and Drug Administration (FDA) that the agency has extended its review period for its long-acting testosterone undecanoate injection for men diagnosed with hypogonadism, from Sept. 2, 2009 to Dec. 2, 2009.

3 Sep 2009

Dr. Samadi of the Mount Sinai Medical Center stresses on prostate cancer awareness

September signifies the start of fall, back to school and back to homework. September is also National Prostate Cancer Awareness Month. The awareness month was proclaimed by President Bush in 2003, and bolstered later that year by former New York mayor Rudy Giuliani, a prostate cancer survivor, who became the spokesman for the National Prostate Cancer Coalition.

2 Sep 2009

Weight gain in men linked with risk of prostate cancer

Body mass in younger and older adulthood, and weight gain between these periods of life, may influence a man's risk for prostate cancer. This risk varies among different ethnic populations, according to results of a study in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

2 Sep 2009

Sexual impairment common among men undergoing chronic hepatitis C treatment

Sexual impairment is common among men with chronic hepatitis C undergoing antiviral therapy, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

1 Sep 2009

Research study to identify the appropriate amount of DHA required for promoting optimal heart health

A team of French scientists have found the dose of DHA (docosahexaenoic acid) that is "just right" for preventing cardiovascular disease in healthy men. In a research report appearing in the September 2009 print issue of The FASEB Journal, the scientists show that a 200 mg dose of DHA per day is enough to affect biochemical markers that reliably predict cardiovascular problems, such as those related to aging, atherosclerosis, and diabetes. This study is the first to identify how much DHA is necessary to promote optimal heart health.

1 Sep 2009

High incidence of HIV infection is found among South African gays

New research from UCSF examining HIV among men who have sex with men (MSM) in the township of Soweto in South Africa has found that a third of gay-identified men are infected with HIV.

31 Aug 2009

Gen-Probe commences clinical study to secure U.S. approval of the PROGENSA PCA3 assay

DiagnoCure Inc. (TSX: CUR) announced that Gen-Probe, Inc. (NASDAQ: GPRO), its partner for the development and commercialization of the PCA3 prostate cancer test, has confirmed today the beginning of a U.S. clinical study intended to secure U.S. regulatory approval of the PROGENSA(R) PCA3 assay, a new molecular test that may help determine the need for a repeat prostate biopsy.

28 Aug 2009

Movember to present at the LIVESTRONG Global Cancer Summit

Staggering statistic: cancer kills more people every year than AIDS, tuberculosis and malaria combined. Joining more than 250 advocates from around the world, Adam Garone, co-founder and CEO of Movember, the world's largest charity for men's health, will present at the LIVESTRONG Global Cancer Summit in Dublin, Ireland, August 24 - 26.

27 Aug 2009

Rizer XL's male enhancement formula increases sexual desire, pleasure and performance

Increasing pressure on men to perform sexually and higher expectations of men's sexual performance from women has led to an astounding rise in sales, says Rizer XL, the leading provider of premium male enhancement pills.

27 Aug 2009

Cannabis chemicals halt prostate cancer growth

Active chemicals in cannabis have been shown to halt prostate cancer cell growth according to research published in the British Journal of Cancer.

26 Aug 2009

Increased risk of death for men with heart conditions undergoing RT with hormone therapy for prostate cancer

Men with coronary artery disease-induced congestive heart failure or heart attack who receive hormone therapy before or along with radiation therapy for treatment of prostate cancer have an associated increased risk of death, according to a study in the August 26 issue of JAMA.

26 Aug 2009

Men's Health News

ESHRE's first workshop on male infertility

Research study investigates survival rates of prostate cancer patients across time periods

Defective gene is linked to male infertility

Men and healthcare professionals urged to take proactive approach to prostate cancer

GTx to continue its toremifene Phase III high grade PIN clinical trial for prevention of prostate cancer

Body mass in younger and older adulthood linked to prostate cancer risks

Lack of awareness in aged men reagarding prostate cancer treatment options

Prostate cancer treatment options discussed in a study

Active cannabis chemicals halt prostate cancer cell growth

FDA extends review period for Endo Pharmaceuticals' testosterone undecanoate

Dr. Samadi of the Mount Sinai Medical Center stresses on prostate cancer awareness

Weight gain in men linked with risk of prostate cancer

Sexual impairment common among men undergoing chronic hepatitis C treatment

Research study to identify the appropriate amount of DHA required for promoting optimal heart health

High incidence of HIV infection is found among South African gays

Gen-Probe commences clinical study to secure U.S. approval of the PROGENSA PCA3 assay

Movember to present at the LIVESTRONG Global Cancer Summit

Rizer XL's male enhancement formula increases sexual desire, pleasure and performance

Cannabis chemicals halt prostate cancer growth

Increased risk of death for men with heart conditions undergoing RT with hormone therapy for prostate cancer

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest News